SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-127776
Filing Date
2022-04-28
Accepted
2022-04-28 16:41:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d267931ddefa14a.htm DEFA14A 11402
2 GRAPHIC g267931sp0001.jpg GRAPHIC 176940
3 GRAPHIC g267931sp0002.jpg GRAPHIC 54914
  Complete submission text file 0001193125-22-127776.txt   321277
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Filer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40656 | Film No.: 22867400
SIC: 2836 Biological Products, (No Diagnostic Substances)